Abstract
Increasingly. the role of immunologic mechanisms in the etiology and progression of neurologic diseases, particularly those involving demyelination, is being recognized. In appreciation of this, the Rockefeller Foundation recently convened a small group of neurologists and immunologists to exchange their views not only with respect to pathogenesis, but also with emphasis on the application of immunologic modalities to the treatment of these diseases. Among the participants was Sir Peter B. Medawar, Nobel Laureate, of the Medical Research Council, Clinical Research Centre at Harrow, England.The following special report on the conference in Bellagio. Italy, was prepared by Dr. Medawar.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
